Emergent BioSolutions (EBS) Other Working Capital Changes (2010 - 2026)

Emergent BioSolutions' Other Working Capital Changes history runs 10 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• On a quarterly basis, Other Working Capital Changes rose 1166.67% year-over-year to $3.2 million in Q1 2026; TTM through Mar 2026 was $8.7 million, a 1066.67% increase from a year earlier, with the FY2025 full-year figure at $5.2 million, up 125.62% from the prior year.
• Other Working Capital Changes fell to $3.2 million in Q1 2026 per EBS's latest filing, from $4.1 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $16.6 million in Q1 2022 and bottomed at -$166.0 million in Q2 2024.
• The 5-year median for Other Working Capital Changes is $2.1 million (2025), against an average of -$10.8 million.
• Across the five-year window, Other Working Capital Changes plunged 320.0% in 2023 and soared 1166.67% in 2026, its largest moves.
• Year by year, Other Working Capital Changes stood at $5.4 million in 2022, then slipped by 24.07% to $4.1 million in 2023, then plunged by 136.59% to -$1.5 million in 2024, then surged by 373.33% to $4.1 million in 2025, then decreased by 21.95% to $3.2 million in 2026.
• Per Business Quant, the three latest EBS Other Working Capital Changes figures stand at $3.2 million (Q1 2026), $4.1 million (Q4 2025), and $1.2 million (Q3 2025).